228 related articles for article (PubMed ID: 18431092)
1. Minocycline-induced hyperpigmentation in rheumatoid arthritis.
Fay BT; Whiddon AP; Puumala S; Black NA; O'Dell JR; Mikuls TR
J Clin Rheumatol; 2008 Feb; 14(1):17-20. PubMed ID: 18431092
[TBL] [Abstract][Full Text] [Related]
2. The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population.
Roberts G; Capell HA
J Rheumatol; 2006 Jul; 33(7):1254-7. PubMed ID: 16758512
[TBL] [Abstract][Full Text] [Related]
3. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser.
Alster TS; Gupta SN
Dermatol Surg; 2004 Sep; 30(9):1201-4. PubMed ID: 15355359
[TBL] [Abstract][Full Text] [Related]
4. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous hyperpigmentation in a patient treated with minocycline for rheumatoid arthritis].
Prouteau C; Guennoc X; Tisseau L; Darrieux L; Safa G
Ann Dermatol Venereol; 2018 Feb; 145(2):152-154. PubMed ID: 29128240
[No Abstract] [Full Text] [Related]
6. Minocycline-induced cutaneous hyperpigmentation: confocal laser scanning microscope analysis.
Dodiuk-Gad RP; de Morentin HM; Schafer J; Harel A; Neudorfer M; Misonzhnik F; Gitstein G; Rozenman D; Tur E; Brenner S
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):435-9. PubMed ID: 16643143
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Sawada T; Inokuma S; Sato T; Otsuka T; Saeki Y; Takeuchi T; Matsuda T; Takemura T; Sagawa A;
Rheumatology (Oxford); 2009 Sep; 48(9):1069-72. PubMed ID: 19321513
[TBL] [Abstract][Full Text] [Related]
8. Minocycline-induced hyperpigmentation.
Hung PH; Caldwell JB; James WD
J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
[TBL] [Abstract][Full Text] [Related]
9. Treatment of resistant rheumatoid arthritis with minocycline: an open study.
Langevitz P; Bank I; Zemer D; Book M; Pras M
J Rheumatol; 1992 Oct; 19(10):1502-4. PubMed ID: 1334514
[TBL] [Abstract][Full Text] [Related]
10. Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis.
Scherrer JF; Virgo KS; Zeringue A; Bucholz KK; Jacob T; Johnson RG; True WR; Carney RM; Freedland KE; Xian H; Caplan L; McDonald J; Eisen SA
Gen Hosp Psychiatry; 2009; 31(4):353-9. PubMed ID: 19555796
[TBL] [Abstract][Full Text] [Related]
11. Rate and causes of infliximab discontinuation in patients with rheumatoid arthritis in a private clinical practice.
Bertoli AM; Strusberg I; Baravalle M; Betelu Z; Calás D; Morales L; Strusberg AM
J Clin Rheumatol; 2008 Dec; 14(6):313-7. PubMed ID: 18690164
[TBL] [Abstract][Full Text] [Related]
12. Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy.
Kloppenburg M; Mattie H; Douwes N; Dijkmans BA; Breedveld FC
J Rheumatol; 1995 Apr; 22(4):611-6. PubMed ID: 7791150
[TBL] [Abstract][Full Text] [Related]
13. Minocycline treatment for rheumatoid arthritis: an open dose finding study.
Breedveld FC; Dijkmans BA; Mattie H
J Rheumatol; 1990 Jan; 17(1):43-6. PubMed ID: 2313671
[TBL] [Abstract][Full Text] [Related]
14. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
15. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis.
Bernatsky S; Clarke AE; Suissa S
Arch Intern Med; 2008 Feb; 168(4):378-81. PubMed ID: 18299492
[TBL] [Abstract][Full Text] [Related]
16. Minocycline-induced hyperpigmentation in leprosy.
Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
[TBL] [Abstract][Full Text] [Related]
17. Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial responders.
Thurlings RM; Vos K; Gerlag DM; Tak PP
Arthritis Rheum; 2008 Dec; 58(12):3657-64. PubMed ID: 19035505
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal prophylactic therapy among patients with arthritis treated by rheumatology specialists.
Garcia EB; Michaud K; Wolfe F
J Rheumatol; 2006 Apr; 33(4):779-84. PubMed ID: 16511939
[TBL] [Abstract][Full Text] [Related]
19. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.
Chan G; Goh F; Hodgson T; Hsu E; Johnstone D; Ly J; Platt T; Rodrigues E; Tsai W; Hider P; Gray A; Highton J
N Z Med J; 2008 May; 121(1274):34-41. PubMed ID: 18535644
[TBL] [Abstract][Full Text] [Related]
20. Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.
Smith CJ; Sayles H; Mikuls TR; Michaud K
Arthritis Res Ther; 2011; 13(5):R168. PubMed ID: 22008667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
